A non-transferrin-bound serum iron in idiopathic hemochromatosis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The nature of iron in the serum of patients with idiopathic hemochromatosis has been studied utilizing an isotope labeling method and results have been compared with those from normal individuals and patients with other forms of liver disease. Between 2 and 4% of a tracer dose of 59Fe added to normal serum was retained by DEAE Sephadex and has been designated non-transferrin-bound. Alcoholic liver disease, chronic active hepatitis, and iron deficiency have no effect on this fraction. In idiopathic hemochromatosis 34.6 +/- 3.9% of the added iron was not bound to transferrin at diagnosis, representing approximately 700 microgram Fe/liter serum. Treatment lowers this fraction before serum iron concentration falls to normal. The majority of the non-transferrin-bound iron is of low molecular weight and is not bound to albumin. The presence of this fraction may contribute significantly to the development of tissue siderosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*
Davis, B. J. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1964.tb14213.x · Cited by 18,892
THE PLASMA-TO-CELL CYCLE OF TRANSFERRIN*
Jandl, J. H., & Katz, J. H. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104718 · Cited by 432
Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity
Hershko, C., Graham, G., Bates, G. W., & Rachmilewitz, E. A. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb03662.x · Cited by 423
Serum Ferritin in Patients with Iron Overload and with Acute and Chronic Liver Diseases
Prieto, J., Barry, M., & Sherlock, S. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80092-8 · Cited by 343
Self-citationInternational Committee for Standardization in Hematology
(1971) · British Journal of Haematology · doi:10.1111/j.1365-2141.1971.tb07057.x · Cited by 151
Idiopathic Hemochromatosis in a Young Female
Lamon, J. M., Marynick, S. P., Rosenblatt, R. L., & Donnelly, S. (1979) · Gastroenterology · doi:10.1016/s0016-5085(79)80146-8 · Cited by 91
Distribution of storage iron as body stores expand in patients with hemochromatosis.
Valberg, L., Jb, S., Pn, M., We, C., & Ludwig, J. (1975) · PubMed · Cited by 67
An evaluation of adsorption methods for measurement of plasma iron-binding capacity.
Cook, J. D. (1970) · PubMed · Cited by 66
Sarkar, B. (1970) · Canadian Journal of Biochemistry · doi:10.1139/o70-208 · Cited by 62
Hepatic Iron Deposition in Humans
FAWWAZ, R. A., WINCHELL, H. S., POLLYCOVE, M., & SARGENT, T. (1967) · Blood · doi:10.1182/blood.v30.4.417.417 · Cited by 45
Research works printed but not linked: 1
- Hershko C, Rachmilewitz E: Non transferrin plasma iron in patients with transferrin iron overload.In Proteins of Liver Storage and transport in Biochemistry and Medicine. RR Crichton (ed). Amsterdam, North Holland Publishing, 1976, p 427
Cited by
The importance of free radicals and catalytic metal ions in human diseases.
Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 704
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Iron trafficking inside the brain
Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 420
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis
Grootveld, M., Bell, J. D., Halliwell, B., Aruoma, O. I., Bomford, A., & Sadler, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83758-9 · Cited by 407
The role of iron in type 2 diabetes in humans
Rajpathak, S. N., Crandall, J. P., Wylie-Rosett, J., Kabat, G. C., Rohan, T. E., & Hu, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.005 · Cited by 363
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359
Livrea, M., Tesoriere, L., Pintaudi, A., Calabrese, A., Maggio, A., Freisleben, H., D'Arpa, D., D'Anna, R., & Bongiorno, A. (1996) · Blood · doi:10.1182/blood.v88.9.3608.bloodjournal8893608 · Cited by 274
Fleming, R. E., Migas, M. C., Holden, C. C., Waheed, A., Britton, R. S., Tomatsu, S., Bacon, B. R., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040548097 · Cited by 273
The importance of non-transferrin bound iron in disorders of iron metabolism
Breuer, W., Hershko, C., & Cabantchik, Z. I. (2000) · Transfusion Science · doi:10.1016/s0955-3886(00)00087-4 · Cited by 270
Brissot, P., Wright, T. L., Ma, W. L., & Weisiger, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112125 · Cited by 256
A Review of Fluorescence Methods for Assessing Labile Iron in Cells and Biological Fluids
Espósito, B. P., Epsztejn, S., Breuer, W., & Cabantchik, Z. I. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5611 · Cited by 241
Role of Ceruloplasmin in Cellular Iron Uptake
Mukhopadhyay, C. K., Attieh, Z. K., & Fox, P. L. (1998) · Science · doi:10.1126/science.279.5351.714 · Cited by 199
Characterization of non-transferrin-bound iron clearance by rat liver.
Wright, T. L., Brissot, P., Ma, W. L., & Weisiger, R. A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67473-3 · Cited by 197
Iron Overload Disorders: Natural History, Pathogenesis, Diagnosis, and Therapy
McLaren, G. D., Muir, W. A., Kellermeyer, R. W., & Jacobs, A. (1983) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368309165764 · Cited by 189
Graham, R. M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4725 · Cited by 177
Mechanisms of Iron Accumulation in Hereditary Hemochromatosis
Fleming, R. E., & Sly, W. S. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155838 · Cited by 173
Quantification of Non-Transferrin-Bound Iron in the Presence of Unsaturated Transferrin
Gosriwatana, I., Loreal, O., Lu, S., Brissot, P., Porter, J., & Hider, R. C. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4216 · Cited by 168
Heme Iron, Zinc, Alcohol Consumption, and Colon Cancer: Iowa Women's Health Study
Lee, D.-H., Anderson, K. E., Harnack, L. J., Folsom, A. R., & Jacobs, D. R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh047 · Cited by 162
A direct method for quantification of non-transferrin-bound iron
Singh, S., Hider, R. C., & Porter, J. B. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90088-q · Cited by 152
Nature of nontransferrin‐bound iron
Hider, R. C. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1050.x · Cited by 139
Common Presence of Non–Transferrin-Bound Iron Among Patients With Type 2 Diabetes
Lee, D.-H., Liu, D. Y., Jacobs, D. R., Shin, H.-R., Song, K., Lee, I.-K., Kim, B., & Hider, R. C. (2006) · Diabetes Care · doi:10.2337/dc05-2471 · Cited by 128
2 The development of iron chelating drugs
Porter, J. B., Huehns, E. R., & Hider, R. C. (1989) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(89)80018-6 · Cited by 138
Hershko, C., & Peto, T. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.tb01291.x · Cited by 135
Lee, D., Folsom, A. R., & Jacobs, D. R. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.4.787 · Cited by 139
Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method
Loréal, O., Gosriwatana, I., Guyader, D., Porter, J. B., Brissot, P., & Hider, R. C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80240-8 · Cited by 116
Non‐transferrin‐bound iron is present in serum of hereditary haemochromatosis heterozygotes
Valk, D., Addicks, Gosriwatana, Lü, Hider, & Marx, M. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00628.x · Cited by 114
Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.
van Asbeck, B. S., Verbrugh, H. A., van Oost, B. A., Marx, J. J., Imhof, H. W., & Verhoef, J. (1982) · BMJ · doi:10.1136/bmj.284.6315.542 · Cited by 104
A Fluorescence-Based One-Step Assay for Serum Non-Transferrin-Bound Iron
Breuer, W. V., & Cabantchik, Z. I. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5378 · Cited by 104
Acute Phase Reactants as Novel Predictors of Cardiovascular Disease
Ahmed, M. S., Jadhav, A. B., Hassan, A. J., & Meng, Q. H. (2012) · ISRN Inflammation · doi:10.5402/2012/953461 · Cited by 117
Al‐Refaie, F. N., Wickens, D. G., Wonke, B., Kontoghiorghes, G. J., & Hoffbrand, A. V. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06441.x · Cited by 99
Immune cell functions in iron overload.
de Sousa, M. A. B. (1989) · PubMed · Cited by 98
Non Transferrin Bound Iron: Nature, Manifestations and Analytical Approaches for Estimation
Patel, M., & Ramavataram, D. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0250-7 · Cited by 104
Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy
Gaur, K., Vázquez-Salgado, A. M., Duran-Camacho, G., Dominguez-Martinez, I., Benjamín-Rivera, J. A., Fernández-Vega, L., Carmona‐Sarabia, L., García, A. C., Pérez-Deliz, F., Román, J. A. M., et al. (2018) · Inorganics · doi:10.3390/inorganics6040126 · Cited by 97
Regulation of systemic iron homeostasis: how the body responds to changes in iron demand
Anderson, G. J., Darshan, D., Wilkins, S. J., & Frazer, D. M. (2007) · BioMetals · doi:10.1007/s10534-006-9030-2 · Cited by 117
Fletcher, L. M., Halliday, J. W., & Powell, L. W. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01836.x · Cited by 86
Iron-mediated DNA damage: Sensitive detection of DNA strand breakage catalyzed by iron
Toyokuni, S., & Sagripanti, J. (1992) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(92)84069-y · Cited by 84
Lack of hepatic transferrin receptor expression in hemochromatosis
Sciot, R., Paterson, A. C., van den Oord, J. J., & Desmet, V. J. (1987) · Hepatology · doi:10.1002/hep.1840070507 · Cited by 84
Wessling‐Resnick, M. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.129 · Cited by 108
Wessling‐Resnick, M. (1999) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239991209318 · Cited by 83
Kartikasari, A. E. R., Georgiou, N., Visseren, F. L. J., Kats-Renaud, H. J. V., van Asbeck, B. S., & Marx, J. J. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4700fje · Cited by 76
Non‐transferrin‐bound iron and cellular toxicity
Anderson, G. J. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01828.x · Cited by 66
Pathophysiology of Hereditary Hemochromatosis
Fleming, R. E., Britton, R. S., Waheed, A., Sly, W. S., & Bacon, B. R. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-923313 · Cited by 76
Barosi, G., Arbustini, E., Gavazzi, A., Grasso, M., & Pucci, A. (1989) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1989.tb01229.x · Cited by 64
Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis
Parrow, N. L., Li, Y., Feola, M., Guerra, A., Casu, C., Prasad, P., Mammen, L., Ali, F., Vaicikauskas, E., Rivella, S., et al. (2019) · Blood · doi:10.1182/blood.2018893099 · Cited by 58
Harrison, P., Neilson, J. R., Marwah, S., Madden, L., Bareford, D., & Milligan, D. W. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.10.853 · Cited by 58
Non-transferrin-bound iron uptake by rat liver. Role of membrane potential difference.
Wright, T. L., Fitz, J., & Weisiger, R. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77953-8 · Cited by 57
Lee, D.-H., & Jacobs, D. R. (2004) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00344-x · Cited by 54
Heme: The Lord of the Iron Ring
Voltarelli, V. A., de Souza, R. W. A., Miyauchi, K., Hauser, C. J., & Otterbein, L. E. (2023) · Antioxidants · doi:10.3390/antiox12051074 · Cited by 57
Regulation of the hepatic transferrin receptor in hereditary hemochromatosis†
Lombard, M. G., Bomford, A. B., Hynes, M., Naoumov, N. V., Roberts, S., Crowe, J., & Williams, R. L. (1989) · Hepatology · doi:10.1002/hep.1840090102 · Cited by 54
Non-transferrin-bound iron in long-term transfusion in children with congenital anemias
Wang, W. C., Ahmed, N. K., & Hanna, M. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80832-0 · Cited by 53
Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate
Chenoufi, N., Loréal, O., Drénou, B., Cariou, S., Hubert, N., Leroyer, P., Brissot, P., & Lescoat, G. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80432-1 · Cited by 52
Pathogenesis of hereditary hemochromatosis
Fleming, R. E., Britton, R. S., Waheed, A., Sly, W. S., & Bacon, B. R. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.06.004 · Cited by 50
Non‐Transferrin‐Bound Iron in Alcohol Abusers
de Feo, T. M., Fargion, S., Duca, L., Cesana, B. M., Boncinelli, L., Lozza, P., Cappellini, M. D., & Fiorelli, G. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02152.x · Cited by 48
Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy.
Harrison, P., Marwah, S., Hughes, R. T., & Bareford, D. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.4.350 · Cited by 48
Galleano, M., & Puntarulo, S. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00049-a · Cited by 48
Shetty, J. K., Prakash, M., & Ibrahim, M. S. (2008) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-008-0016-4 · Cited by 48
Iron, Iron‐binding Proteins and Immune System Cellsa
de Sousa, M. A. B., Breedvelt, F., Dynesius‐Trentham, R., Trentham, D. E., & Lum, J. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb55515.x · Cited by 48
Physiological implications of NTBI uptake by T lymphocytes
Pinto, J. P., Arezes, J., Dias, V., Oliveira, S. J., Vieira, I. H., Costa, M., Vos, M. R. J., Carlsson, A., Rikers, Y. G. M., Rangel, M., et al. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00024 · Cited by 49
Weinberg, E. D. (1982) · Nutrition and Cancer · doi:10.1080/01635588209513761 · Cited by 48
Duarte, T. L., Caldas, C., Santos, A. G., Silva‐Gomes, S., Santos-Gonçalves, A., Martins, M. J., Porto, G., & Lopes, J. M. (2016) · Redox Biology · doi:10.1016/j.redox.2016.11.013 · Cited by 51
Angoro, B., Motshakeri, M., Hemmaway, C. J., Svirskis, D. M., & Sharma, M. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.04.004 · Cited by 46
Iron status and cellular immune competence
Good, M. F., Powell, L. W., & Halliday, J. W. (1988) · Blood Reviews · doi:10.1016/0268-960x(88)90007-0 · Cited by 46
Transferrin receptor 2 mediates uptake of transferrin-bound and non-transferrin-bound iron
Graham, R. M., Reutens, G. M., Herbison, C. E., Delima, R. D., Chua, A. C. G., Olynyk, J. K., & Trinder, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.10.009 · Cited by 38
Regulation of hepatic transferrin, transferrin receptor and ferritin genes in human siderosis
Pietrangelo, A., Rocchi, E., Ferrari, A., Ventura, E., & Cairo, G. (1991) · Hepatology · doi:10.1002/hep.1840140623 · Cited by 42
Weinberg, E. D. (1981) · Biological Trace Element Research · doi:10.1007/bf02789123 · Cited by 45
Intracellular and Extracellular Labile Iron Pools
Cabantchik, Z. I., Kakhlon, O., Epsztejn, S., Zanninelli, G., & Breuer, W. V. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0593-8_4 · Cited by 44
Non‐transferrin‐bound iron and hepatic dysfunction in African dietary iron overload
McNamara, L., MacPhail, A. P., Mandishona, E., Bloom, P. D., Paterson, A. C., Rouault, T. A., & Gordeuk, V. R. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01830.x · Cited by 39
Non‐Transferrin Plasma Iron in β‐Thalassaemia/Hb E and Haemoglobin H Diseases
Anuwatanakulchai, M., Wasi, P., Pootrakul, P., & Thuvasethakul, P. (1984) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1984.tb02171.x · Cited by 39
Non-transferrin-bound iron species in the serum of hypotransferrinaemic mice
Simpson, R. J., Cooper, C. E., Raja, K. B., Halliwell, B. B., Evans, P., Arouma, O. I., Singh, S. R. K., & Konijn, A. M. (1992) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(92)90090-h · Cited by 38
Induction of oxidative single- and double-strand breaks in DNA by ferric citrate
Toyokuni, S., & Sagripanti, J. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90050-5 · Cited by 41
Characterisation of citrate and iron citrate uptake by cultured rat hepatocytes
Graham, R. M., Morgan, E. H., & Baker, E. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80156-6 · Cited by 37
Pharmacology of Iron Transport
Byrne, S. L., Krishnamurthy, D., & Wessling‐Resnick, M. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134648 · Cited by 38
Oral iron chelators: Prospects for future development
Porter, J. B. (1989) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1989.tb00300.x · Cited by 36
Etiologies, Consequences, and Treatment of Iron Overload
Gordeuk, V. R., McLaren, G. D., Samowitz, W. S., & Rouault, T. A. (1994) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369409084674 · Cited by 36
Pathogenesis of genetic haemochromatosis
Stremmel, W., Riedel, H.-D., Niederau, C., & Strohmeyer, G. W. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb02031.x · Cited by 37
Brown, J. X., Buckett, P. D., & Wessling‐Resnick, M. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.02.016 · Cited by 36
Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron
Trinder, D., & Morgan, E. (1997) · Hepatology · doi:10.1053/jhep.1997.v26.pm0009303500 · Cited by 34
Mechanisms of ferric citrate uptake by human hepatoma cells
Trinder, D., & Morgan, E. H. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.2.g279 · Cited by 31
Valerio, L. G., & Petersen, D. R. (2000) · Experimental and Molecular Pathology · doi:10.1006/exmp.1999.2278 · Cited by 30
Chronic liver iron overload in the baboon by ferric nitrilotriacetate
Brissot, P., Farjanel, J., Bourel, D., Campion, J. P., Guillouzo, A., Rattner, A., Deugnier, Y., Desvergne, B., Ferrand, B., Simon, M., et al. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01296163 · Cited by 27
Richardson, D. R., Chua, A. C. G., & Baker, E. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90007-0 · Cited by 26
Acquisition, storage and release of iron by cultured human hepatoma cells
Hirsh, M., Konijn, A. M., & Iancu, T. C. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00221-5 · Cited by 28
(1987) · PubMed Central · Cited by 26
The rise in the total iron-binding capacity after iron overdose
Burkhart, K., Kulig, K. W., Hammond, K. B., Pearson, J. R., Ambruso, D. R., & Rumack, B. H. (1991) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81609-9 · Cited by 26
Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron
Prakash, M., Upadhya, S., & Prabhu, R. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2005.04.024 · Cited by 28
Cable, E. E., Connor, J. R., & Isom, H. C. (1998) · Europe PMC (PubMed Central) · Cited by 24
Yu, J., Yu, Z. K., & Wessling‐Resnick, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34675 · Cited by 27
Artificial Intelligence for Vaccine Design
McCaffrey, P. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1892-9_1 · Cited by 24
Chua, A. C. G., Ingram, H. A., Raymond, K. N., & Baker, E. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03525.x · Cited by 23
Properties and hepatic metabolism of non-transferrin-bound iron
Batey, R. G., Shamir, S., & Wilms, J. (1981) · Digestive Diseases and Sciences · doi:10.1007/bf01295972 · Cited by 23
Self-citationBrissot, P., Bolder, U., Schteingart, C. D., Arnaud, J., & Hofmann, A. F. (1997) · Hepatology · doi:10.1002/hep.510250625 · Cited by 22
Growth of human tumor cell lines in transferrin-free, low-iron medium
Neumannova, V., Richardson, D. R., Kriegerbecková, K., & Kovár̆, J. (1995) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02634316 · Cited by 22
The Immunoregulatory Nature of Iron. II. Lymphocyte Surface Marker Expression
Bryan, C. F., Leech, S. H., & Bozelka, B. E. (1986) · Journal of Leukocyte Biology · doi:10.1002/jlb.40.5.589 · Cited by 22
Intravenous iron supplementation in the anaemia of renal and cardiac failure—a double-edged sword?
Slotki, I. N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1102 · Cited by 24
Role of Non-Transferrin-Bound Iron in The Pathogenesis of Iron Overload and Toxicity
Brissot, P., & Loréal, O. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0593-8_3 · Cited by 21
Holland, H. K., & Spivak, J. L. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30641-1 · Cited by 21
Interaction of serum albumin with the Fe(III)-citrate complex
Løvstad, R. A. (1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90115-u · Cited by 20
Wright, T. L., & Lake, J. R. (1990) · Hepatology · doi:10.1002/hep.1840120309 · Cited by 20
Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes
Hoepelman, I. M., Bezemer, W. A., van Doornmalen, E. J. P., Verhoef, J., & Marx, J. J. M. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb04328.x · Cited by 22
Metadata
- Authors
- Batey, R. G., Fong, P. L. C., Shamir, S., & Sherlock, S.
- Affiliations
- Royal Prince Alfred Hospital (AU)
- ORCID
- Batey, R. G.
- Venue
- Digestive Diseases and Sciences
- Published
- 1980-05
- Volume
- 25
- Issue
- 5
- Pages
- 340-346
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W1979601721
- Cited by
- 162
- References
- 16
- Citations by year
- 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- idiopathic hemochromatosis, non-transferrin-bound iron, serum iron, transferrin, iron-59, iron overload, liver disease, iron deficiency
- MeSH terms
- Iron Deficiencies, Binding Sites, Bloodletting, Chronic Disease, Dialysis, Electrophoresis, Polyacrylamide Gel, Female, Hemochromatosis, Hepatitis, Humans, Iron, Liver Cirrhosis, Alcoholic, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.